首页> 外文期刊>Current opinion in obstetrics & gynecology >Embryonic stem cells: advances toward potential therapeutic use.
【24h】

Embryonic stem cells: advances toward potential therapeutic use.

机译:胚胎干细胞:向潜在的治疗用途发展。

获取原文
获取原文并翻译 | 示例
       

摘要

Established lines of human pluripotent stem cells provide a convenient tool for investigating cell differentiation in a way that is pertinent to human embryonic development, providing insights into the causes of birth defects and diseases such as cancer that involve aberrant cell proliferation and differentiation. In principle, human pluripotent stem cells, including embryonic stem and embryonic germ cells, are capable of differentiating into all of the cell types that are present in the adult human. They therefore have the potential to provide a source of tissues for replacement in diseases in which native cell types are inactivated or destroyed. Intense media and public interest has surrounded the announcement of human pluripotent stem cells derivation, focusing on the ethical implications of embryo-related work and on the prospects of an unlimited source of tissues for transplantation-based treatments. Recent studies have focused on identifying method for culture of these cells and inducing their differentiation into specific cell types.
机译:已建立的人类多能干细胞系为研究细胞分化提供了一种方便的工具,其方式与人类胚胎发育有关,从而可以洞悉先天缺陷和疾病的病因,例如涉及异常细胞增殖和分化的癌症。原则上,人类多能干细胞,包括胚胎干细胞和胚胎生殖细胞,能够分化为成年人类中存在的所有细胞类型。因此,它们具有提供替代组织来源的潜力,以替代其中天然细胞类型被灭活或破坏的疾病。激烈的媒体和公众关注围绕着人类多能干细胞衍生的宣布,关注胚胎相关工作的伦理意义以及基于移植治疗的无限组织来源的前景。最近的研究集中于鉴定用于培养这些细胞并诱导其分化成特定细胞类型的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号